Pharmafile Logo

News and Press Releases

Bionova Scientific announces plans for new Plasmid DNA GMP facility

Facility in The Woodlands, Texas, US, to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025 3 June 2024 -- California, US --...

Category: BioManufacturing, Manufacturing and Packing, Pharmaceutical
Posted: June 3, 2024

Bionova Scientific
3288 Laurelview Ct. Fremont, CA 94538

Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing

Partnership to develop and implement Cellular Origins’ robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult’s Stevenage Manufacturing Innovation Centre, UK 29 May 2024 -- Cambridge, UK,...

Category: BioManufacturing, Biotechnology, Drug Discovery
Posted: May 29, 2024

Cellular Origins
hello@cellularorigins.com
TTP Campus Cambridge Road Melbourn SG8 6HQ

Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness Within 24 Weeks and Initial Hearing Improvements in a Second Child at Six Weeks

Preliminary data detailed in an ASGCT oral presentation include results for one of the youngest children in the world to receive a gene therapy for genetic deafness Ongoing phase 1/2...

Category: Biotechnology, Clinical Trials
Posted: May 8, 2024

Regeneron
ukinfo@regeneron.com
The Charter Building, Vine Street, Uxbridge, Middlesex, United Kingdom, UB8 1JG

First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, New Jersey, US

With the recent FDA approval of LYFGENIA, developed by bluebird bio, Minaris Regenerative Medicine North America is now supporting a commercial cell and gene therapy (CGT) product The first commercial...

Category: BioManufacturing, Biotechnology
Posted: May 8, 2024

Minaris Regenerative Medicine
contact@rm.minaris.de
4 Pearl Court, Allendale, New Jersey, 07401

Broken String Biosciences and the Francis Crick Institute collaborate to advance ALS research

Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis 07 May 2024 -- Cambridge and London,...

Category: Drug Discovery, Pharmaceutical
Posted: May 7, 2024

Broken String Biosciences
info@brokenstringbio.com
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR

Revolutionising Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable 2 May 2024 -- Raleigh, North Carolina -- ProPharma, the leading global provider of regulatory, clinical and compliance services...

Category: BioManufacturing, Clinical Trials, Drug Discovery
Posted: May 2, 2024

ProPharma
107 West Hargett St. Raleigh, NC 27601

Cellular Origins, a TTP Company, appoints Peter Crossley as Chief Operating Officer

Product and technology innovator will build team to further develop and deliver Cellular Origins’ products for cell and gene therapy manufacture at scale 25 January 2024 -- Cambridge, UK --...

Category: BioManufacturing
Posted: January 25, 2024

Cellular Origins
hello@cellularorigins.com
TTP Campus Cambridge Road Melbourn SG8 6HQ

Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialisation

Appointment of Vincent Smith PhD, as chief technology officer and Jessica Rich as VP of Business Development Follows Broken String’s successful $15m Series A fundraising round in September 2023 Will...

Category: Biotechnology
Posted: October 4, 2023

Broken String Biosciences
info@brokenstringbio.com
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR

Broken String Biosciences Closes $15m Series A Funding Round

Funds to support further development and commercialisation of the company’s INDUCE-seq DNA break mapping technology Platform technology provides in situ off-target measurement in clinically relevant cells to accelerate the progression...

Category: Biotechnology
Posted: September 18, 2023

Broken String Biosciences
info@brokenstringbio.com
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR